Literature DB >> 3140860

Maternal inspired oxygen concentration and neonatal status for caesarean section under general anaesthesia. Comparison of effects of 33% or 50% oxygen in nitrous oxide.

E G Lawes1, B Newman, M J Campbell, M Irwin, S Dolenska, T A Thomas.   

Abstract

The relationship between maternal FIO2 and umbilical venous PO2, PCO2, pH and neonatal Apgar and TSR (time to sustained respiration) scores was studied in 35 patients undergoing Caesarean section under general anaesthesia. Patients were allocated randomly to breathe an FIO2 of either 0.5 or 0.33. Umbilical venous blood was collected at the time of delivery, and TSR and 1- and 5-min Apgar scores recorded. Mean values for umbilical venous blood were: PO2 3.9 kPa and 3.7 kPa; PCO2 6.2 kPa and 6.2 kPa; pH 7.30 and 7.31 (50% and 33% groups, respectively (P greater than 0.05]. No differences were found between groups for 1- or 5-min Apgar scores or TSR values. It is concluded that no difference in fetal outcome or acid-base status can be detected when maternal FIO2 is decreased from 0.5 to 0.33, and that the use of 33% oxygen in 66% nitrous oxide appears to be safe for neonates who have not suffered fetal distress before delivery.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140860     DOI: 10.1093/bja/61.3.250

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Maternal oxygen administration for fetal distress.

Authors:  Bukola Fawole; G Justus Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 2.  [Caesarean sections under regional anesthesia: pros and cons of supplementary oxygen].

Authors:  H Aust; M Zemlin; F Woernle; H Wulf; D Rüsch
Journal:  Anaesthesist       Date:  2013-03       Impact factor: 1.041

Review 3.  Effects of obstetric analgesics and anesthetics on the neonate : a review.

Authors:  Jay E Mattingly; John D'Alessio; Jaya Ramanathan
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.